Patents by Inventor Yan Zhu

Yan Zhu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180021335
    Abstract: Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control. The compounds of the invention are orally active.
    Type: Application
    Filed: July 26, 2017
    Publication date: January 25, 2018
    Inventors: Xin Chen, Peng Cheng, L. Edward Clemens, Jeffrey D. Johnson, Jingyuan Ma, Alison Murphy, Imad Nashashibi, Christopher J. Rabbat, Jiangao Song, Maria E. Wilson, Yan Zhu, Zuchun Zhao
  • Publication number: 20180006811
    Abstract: A method and system for group-oriented encryption and decryption that supports the implementation of the designation and revocation functions of decryption users in a large-scale group.
    Type: Application
    Filed: November 5, 2015
    Publication date: January 4, 2018
    Inventors: Yan ZHU, Feng PU, Ruyun YU, Dandan LI
  • Publication number: 20170369663
    Abstract: Pre-impregnated composite material (prepreg) that can be cured/molded to form aerospace composite parts. The prepreg includes carbon reinforcing fibers and an uncured resin matrix. The resin matrix includes an epoxy component that is a combination of a hydrocarbon epoxy novolac resin and a trifunctional epoxy resin and optionally a tetrafunctional epoxy resin. The resin matrix includes polyethersulfone as a toughening agent and a thermoplastic particle component.
    Type: Application
    Filed: June 14, 2017
    Publication date: December 28, 2017
    Inventors: Yan Zhu, Gordon Emmerson, Yen-Seine Wang, Maureen Boyle, Jessica Leandro
  • Patent number: 9853462
    Abstract: A series-parallel battery system with a buffer resistor coupled to each junction of batteries or battery cells. Buffer resistors on the same row are coupled to a measurement node. Terminals of the battery system and the measurement nodes are treated as measurement points that are coupled to a conventional battery management unit. The buffer resistors provide a means for limiting in-rush current and a means for maintaining voltage balance across the row of batteries in the parallel columns of batteries. A control unit in series with each series of batteries monitors current in the series and comprises a switch to deactivate the column when the current exceeds a set of predetermined current levels.
    Type: Grant
    Filed: April 1, 2015
    Date of Patent: December 26, 2017
    Assignee: Amperex Technology Limited
    Inventor: Li-Yan Zhu
  • Publication number: 20170359177
    Abstract: A cryptographic decision-making of set membership is a method or system which make a secure decision-making for positive membership e?S or negative membership e?S in an unforgeable and non-repudiation way for any element e and a set S. The proposed method of the present invention comprises: acquire a set U={e1, . . . , en} and map each element ei in U into a random point vi in a cryptography space; acquire a set S={e?1, . . . , e?m}?U, determine a random point v?i corresponding to each element e?i in the set S, and construct a function ƒS(x) according to all random points v?i; introduce a random secret ? to generate ƒS(?) by using the function ƒS(x), and produce a public parameter mpk according to the random secret ?; and generate the cryptographic representation of set S by using the function ƒS(?) and the public parameter mpk.
    Type: Application
    Filed: February 13, 2015
    Publication date: December 14, 2017
    Inventors: Yan ZHU, Ruyun YU, Ruiqi GUO, Xin WANG
  • Publication number: 20170346065
    Abstract: The present disclosure discloses an electric connector and a battery comprising the same. The electric connector includes a leading-out sheet, and a plurality of connecting sheets welded to the leading-out sheet, each connecting sheet comprising at least two welding portions; wherein the leading-out sheet and each connecting sheet are separate parts. The electric connector according to the present disclosure is convenient in welding, simple in structure, low in process cost, stable and reliable in structure and high in safety.
    Type: Application
    Filed: August 21, 2017
    Publication date: November 30, 2017
    Inventors: LUXIA JIANG, KELI YANG, YAN ZHU, JIANHUA ZHU
  • Publication number: 20170333406
    Abstract: The present invention relates to compounds of formula (I) or formula (II): and to salts thereof, wherein R1-R4 of formula (I) and R1-R3 of formula (II) have any of the values defined herein, and compositions and uses thereof. The compounds are useful as inhibitors of CBP and/or EP300. Also included are pharmaceutical compositions comprising a compound of formula (I) of formula (II) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various CBP and/or EP300-mediated disorders.
    Type: Application
    Filed: August 2, 2017
    Publication date: November 23, 2017
    Applicants: GENENTECH, INC., CONSTELLATION PHARMACEUTICALS, INC.
    Inventors: Marc Adler, Brian K. Albrecht, Sarah Bronner, Kevin X. Chen, Alexandre Côté, Terry Crawford, Patrick Cyr, Jackson Egen, Steven Kauder, Kwong Wah Lai, Jiangpeng Liao, Steven Magnuson, Jeremy Murray, Richard Pastor, F. Anthony Romero, Alexander M. Taylor, Vickie Hsiao-Wei Tsui, Fei Wang, Bing-Yan Zhu
  • Publication number: 20170283424
    Abstract: A compound of Formula I, enantiomers, diasteriomers, tautomers or pharmaceutically acceptable salts thereof, wherein R1, R2 and R3 are defined herein, are useful as inhibitors of one or more Janus kinases. A pharmaceutical composition that includes a compound of Formula I and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient are disclosed.
    Type: Application
    Filed: June 20, 2017
    Publication date: October 5, 2017
    Applicant: Genentech, Inc.
    Inventors: Paul Gibbons, Emily Hanan, Wendy Liu, Joseph P. Lyssikatos, Steven R. Magnuson, Rohan Mendonca, Richard Pastor, Thomas E. Rawson, Michael Siu, Mark E. Zak, Aihe Zhou, Bing-Yan Zhu, Christopher Hurley
  • Publication number: 20170288200
    Abstract: The present disclosure discloses a battery connection sheet, including: a first part, including a first metal sheet, a first buffer portion and a first connection portion, and a second part, including a second metal sheet connected with the first connection portion via electromagnetic pulse welding.
    Type: Application
    Filed: June 19, 2017
    Publication date: October 5, 2017
    Inventors: QINGBO PENG, WEIXIN ZHENG, ZHIPEI LU, YAN ZHU, JIANHUA ZHU
  • Patent number: 9763922
    Abstract: The present invention relates to compounds of formula (I) or formula (II): and to salts thereof, wherein R1-R4 of formula (I) and R1-R3 of formula (II) have any of the values defined herein, and compositions and uses thereof. The compounds are useful as inhibitors of CBP and/or EP300. Also included are pharmaceutical compositions comprising a compound of formula (I) of formula (II) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various CBP and/or EP300-mediated disorders.
    Type: Grant
    Filed: November 25, 2015
    Date of Patent: September 19, 2017
    Assignees: GENENTECH, INC., CONSTELLATION PHARMACEUTICALS, INC.
    Inventors: Marc Adler, Brian K. Albrecht, Sarah Bronner, Kevin X. Chen, Alexandre Côté, Terry Crawford, Patrick Cyr, Jackson Egen, Steven Kauder, Kwong Wah Lai, Jiangpeng Liao, Steven Magnuson, Jeremy Murray, Richard Pastor, F. Anthony Romero, Alexander M. Taylor, Vickie Hsiao-Wei Tsui, Fei Wang, Bing-Yan Zhu
  • Patent number: 9737537
    Abstract: Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control. The compounds of the invention are orally active.
    Type: Grant
    Filed: October 25, 2016
    Date of Patent: August 22, 2017
    Assignee: CYMABAY THERAPEUTICS, INC.
    Inventors: Xin Chen, Peng Cheng, L. Edward Clemens, Jeffrey D. Johnson, Jingyuan Ma, Alison Murphy, Imad Nashashibi, Christopher J. Rabbat, Jiangao Song, Maria E. Wilson, Yan Zhu, Zuchun Zhao
  • Patent number: 9725439
    Abstract: The present invention relates to a quinazoline derivative shown in formula (I) and a preparation method therefor, a pharmaceutical composition comprising the compound shown in formula (I), and an application of the compound in preparing drugs for curing and preventing tumors. The compound of the present invention can irreversibly prevent EGFR phosphorylation, and effectively depress signal transduction of cancer cells, and accordingly has higher anti-tumor activity in vitro and in vivo.
    Type: Grant
    Filed: September 28, 2014
    Date of Patent: August 8, 2017
    Assignees: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD., CENTAURUS BIOPHARMA CO., LTD., LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD.
    Inventors: Dengming Xiao, Yan Zhu, Yuandong Hu, Huting Wang, Jijun Li, Yong Peng, Hui Zhang, Hong Luo, Fansheng Kong, Yongxin Han
  • Publication number: 20170207818
    Abstract: A method for differentiating power distribution areas and phases by using voltage characteristics, where the method includes performing similarity comparison on a voltage curve of a node to be determined and a voltage curve recorded by a concentrator to determine whether the node belongs to a current power distribution area. Using the method for identifying power distribution areas and phases according to voltage characteristics, the problem of inaccurate electric power measurement due to power distribution area archive errors, communication crosstalk, and others is effectively resolved, a collection success rate and meter reading stability of a power distribution area are improved, a line loss rate of a power distribution area is moderately reduced, correctness of ammeter archive information of an SG186 system is ensured, occurrences of power distribution area crossing of carrier communications and ammeter archive errors are eradicated, and delicacy management of a marketing system is realized.
    Type: Application
    Filed: December 18, 2014
    Publication date: July 20, 2017
    Applicants: JIANGSU LINYANG ENERGY CO., LTD., NANJING LINYANG POWER TECH CO., LTD.
    Inventors: Hanxi LU, Yan ZHU
  • Publication number: 20170187017
    Abstract: A battery accommodating device and a battery module including the same are provided. The battery accommodating device includes: an outer insertion-connected assembly comprising outer components; an inner insertion-connected assembly comprising inner components and disposed between the outer components; and a chamber configured to accommodate a battery and defined between the inner components and outer components. Each of the outer components is fitted with an inner component via a sliding rail structure.
    Type: Application
    Filed: March 14, 2017
    Publication date: June 29, 2017
    Inventors: XUEFENG ZHANG, YAN ZHU, QINGBO PENG, JIA LU, WEI LIU
  • Patent number: 9679762
    Abstract: A high electron mobility transistor (HEMT) device with enhanced conductivity in the transistor's non-gated access regions and a method for making the HEMT device is disclosed. In one embodiment, the HEMT device includes a heterojunction comprising a barrier layer formed on a channel layer. One or more intervening layers comprising a material suitable for increasing a fixed charge at the heterojunction is formed on a substantially planar surface of the barrier layer opposite the channel layer in the non-gated access region.
    Type: Grant
    Filed: March 17, 2015
    Date of Patent: June 13, 2017
    Assignee: Toshiba Corporation
    Inventors: Andrew Paul Edwards, Xinyu Zhang, Yan Zhu
  • Publication number: 20170148930
    Abstract: An optoelectronic device having a textured layer is described. In an aspect, a method may be used to produce the optoelectronic device, where the method includes epitaxially growing a semiconductor layer of the optoelectronic device on a growth substrate, and exposing the semiconductor layer to an etching process to create at least one textured surface in the semiconductor layer. The textured semiconductor layer can be referred to as a textured layer. The etching process is performed without the use of a template layer, or similar layer, configured as a mask to generate the texturing. The etching process can be done by one or more of a liquid or solution-based chemical etchant, gas etching, laser etching, plasma etching, or ion etching. The method can also include lifting the semiconductor layer of the optoelectronic device from the growth substrate by, for example, the use of an epitaxial lift off (ELO) process.
    Type: Application
    Filed: February 1, 2017
    Publication date: May 25, 2017
    Inventors: Yan ZHU, Sean SWEETNAM, Brendan M. KAYES, Melissa J. ARCHER, Gang HE
  • Patent number: 9657369
    Abstract: The invention relates to a separation and recovery method for radioactive waste slag and specifically relates to a separation and recovery method for monazite slag. The separation and recovery method comprises the following steps: acid leaching, pressure filtration, water washing, extraction of valuable components and treatment of filtration slag.
    Type: Grant
    Filed: July 24, 2013
    Date of Patent: May 23, 2017
    Assignee: YIYANG HONGYUAN RARE EARTH CO., LTD
    Inventors: Qi Wang, Yuehua Chen, Xiaozhen Cui, Ping Ren, Keqin Liu, Geming Xu, Weiquan Guo, Yan Zhu
  • Patent number: 9629831
    Abstract: Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.
    Type: Grant
    Filed: June 17, 2015
    Date of Patent: April 25, 2017
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Bing-Yan Zhu, Wenrong Huang
  • Patent number: D797104
    Type: Grant
    Filed: September 1, 2016
    Date of Patent: September 12, 2017
    Inventor: Yan Zhu
  • Patent number: D797105
    Type: Grant
    Filed: September 1, 2016
    Date of Patent: September 12, 2017
    Inventor: Yan Zhu